Internal Medicine, Hematology & Oncology · Pensacola, FL
NPI
1083750962
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1545 Airport Blvd Ste 2000
Pensacola, FL, 32504
Phone (850) 416-6933
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
1,670 services
Medicare patients, 2024
624
Average age 74
Drug cost, 2024
$5.8M
2,682 prescriptions
Company payments, 2025
$379
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander Brown was code 99214 (office e&m - established), 802 times for 314 patients. In total Alexander Brown billed 1,670 services in 18 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 802 | 314 | $72.23 | $58K |
| 99213 Office E&M - Established | Office | 408 | 304 | $48.94 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 142 | 51 | $60.45 | $8,583 |
| 99222 Hospital E&M - Initial | Facility | 77 | 75 | $101.01 | $7,778 |
| 99442 Telephone Services | Office | 47 | 41 | $66.95 | $3,147 |
| 99215 Office E&M - Established | Office | 39 | 27 | $111.83 | $4,361 |
| 99204 Office E&M - New | Office | 37 | 37 | $105.56 | $3,906 |
| 99212 Office E&M - Established | Office | 29 | 29 | $28.27 | $820 |
| 99233 Hospital E&M - Subsequent | Facility | 17 | 13 | $95.66 | $1,626 |
| 99441 Telephone Services | Office | 16 | 13 | $30.52 | $488 |
| 99239 Hospital Discharge Management | Facility | 15 | 15 | $78.21 | $1,173 |
| 99203 Office E&M - New | Office | 13 | 13 | $56.52 | $735 |
| 99205 Office E&M - New | Office | 13 | 13 | $147.11 | $1,912 |
By year: 2022 $108K for 1,619 services; 2023 $112K for 1,579 services; 2024 $114K for 1,670 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Brown prescribed most often to Medicare patients was Eliquis (Apixaban), with 132 prescriptions and refills. In total Alexander Brown wrote 2,682 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 132 | 179 | 27 | $108K |
| Anastrozole Generic | 118 | 257 | 32 | $1,870 |
| Oxycodone Hcl Generic | 111 | 113 | 31 | $2,512 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 110 | 110 | 34 | $2,795 |
| Ondansetron Hcl Generic | 100 | 100 | 49 | $1,115 |
| Letrozole Generic | 90 | 174 | 27 | $1,738 |
| Revlimid Lenalidomide | 87 | 88 | Under 11 | $1.4M |
| Prochlorperazine Maleate Generic | 68 | 68 | 40 | $1,169 |
| Prednisone Generic | 67 | 90 | 25 | $300 |
| Valacyclovir Valacyclovir Hcl | 65 | 93 | 15 | $2,499 |
| Ibrance Palbociclib | 63 | 63 | Under 11 | $896K |
| Abiraterone Acetate Generic | 63 | 63 | Under 11 | $103K |
| Temazepam Generic | 62 | 69 | 11 | $684 |
| Gabapentin Generic | 57 | 102 | 21 | $715 |
| Morphine Sulfate Er Morphine Sulfate | 56 | 56 | 15 | $974 |
Brand drugs: - claims; generic drugs: 2,079 claims; opioid claims: 388.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander Brown $379 ($379 in general payments such as food, travel and fees) from 14 companies. The largest payer was Celgene Corporation with $51.71.
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation BMY | 3 | $51.71 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $42.02 |
| Abbvie Inc. ABBV | 2 | $36.29 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $34.28 |
| BeOne Medicines USA, Inc. ONC | 2 | $31.85 |
| Janssen Biotech, Inc. JNJ | 2 | $31.79 |
| Incyte Corporation INCY | 1 | $24.07 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $20.37 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $19.77 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $19.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.